These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7906914)

  • 1. Cirrhosis, Hyperammonemia and Hepatic Encephalopathy. Proceedings of a meeting. Spain, August 10-14, 1992.
    Adv Exp Med Biol; 1993; 341():1-148. PubMed ID: 7906914
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic encephalopathy, hyperammonemia, and ammonia toxicity. Papers presented at the International Symposium on Cirrhosis, Hyperammonemia and hepatic encephalopathy. Valencia, Spain, January 24-27, 1994.
    Adv Exp Med Biol; 1994; 368():1-205. PubMed ID: 7740999
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention and therapy of portosystemic encephalopathy].
    Schmid M
    Schweiz Rundsch Med Prax; 1985 Sep; 74(36):954-7. PubMed ID: 2867591
    [No Abstract]   [Full Text] [Related]  

  • 4. International symposium on cirrhosis, hepatic encephalopathy and ammonium toxicity. Valencia, Spain, November 27-29, 1989. Proceedings.
    Adv Exp Med Biol; 1990; 272():1-265. PubMed ID: 1983312
    [No Abstract]   [Full Text] [Related]  

  • 5. Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease.
    Hadjihambi A; De Chiara F; Hosford PS; Habtetion A; Karagiannis A; Davies N; Gourine AV; Jalan R
    Hepatology; 2017 Apr; 65(4):1306-1318. PubMed ID: 28066916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Positron emission tomography (PET) before and after treatment of hyperammonemia in a patient with decompensated liver cirrhosis].
    Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Murai K; Sadoshima S; Fujishima M; Ichiya Y
    Fukuoka Igaku Zasshi; 1991 Oct; 82(10):521-7. PubMed ID: 1748367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology.
    Butterworth RF
    Drugs; 2019 Feb; 79(Suppl 1):17-21. PubMed ID: 30706423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy.
    Tapper EB; Jiang ZG; Patwardhan VR
    Mayo Clin Proc; 2015 May; 90(5):646-58. PubMed ID: 25865476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.
    Ahmad I; Khan AA; Alam A; Dilshad A; Butt AK; Shafqat F; Malik K; Sarwar S
    J Coll Physicians Surg Pak; 2008 Nov; 18(11):684-7. PubMed ID: 18983791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Sarcopenia and Frailty in Hepatic Encephalopathy Management.
    Lucero C; Verna EC
    Clin Liver Dis; 2015 Aug; 19(3):507-28. PubMed ID: 26195205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cirrhosis and encephalopathy. Attempt at a physiopathologic interpretation].
    Michel H
    Med Chir Dig; 1976; 5(3):131-8. PubMed ID: 12426
    [No Abstract]   [Full Text] [Related]  

  • 12. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment.
    Van Thiel DH; Fagiuoli S; Wright HI; Chien MC; Gavaler JS
    Hepatology; 1994 Jan; 19(1):67-71. PubMed ID: 8276369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperammonemia and hepatic insufficiency].
    SOBERON G; FLORES G; ROSADO A; TORRES GALLARDO J; MORA J; MAGGIO R
    Gac Med Mex; 1963 Mar; 93():203-23. PubMed ID: 13989778
    [No Abstract]   [Full Text] [Related]  

  • 14. Ammonia-related changes in cerebral electrogenesis in healthy subjects and patients with cirrhosis.
    Bersagliere A; Raduazzo ID; Schiff S; Gatta A; Merkel C; Amodio P; Achermann P; Montagnese S
    Clin Neurophysiol; 2013 Mar; 124(3):492-6. PubMed ID: 22999317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Considerations on the EEG of liver cirrhosis with and without encephalopathy].
    Nehlil J
    Rev Neurol (Paris); 1965 Sep; 113(3):363. PubMed ID: 5853443
    [No Abstract]   [Full Text] [Related]  

  • 16. Modern progress in hepatic encephalopathy.
    McPhail MJ; Senvar N; Thomas HC; Taylor-Robinson SD
    QJM; 2010 Nov; 103(11):899-900. PubMed ID: 20356851
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis.
    Ahluwalia V; Betrapally NS; Hylemon PB; White MB; Gillevet PM; Unser AB; Fagan A; Daita K; Heuman DM; Zhou H; Sikaroodi M; Bajaj JS
    Sci Rep; 2016 May; 6():26800. PubMed ID: 27225869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatic encephalopathy in patients with cirrhosis: new aspects and practical recommendations].
    Ditisheim S; Spahr L
    Rev Med Suisse; 2010 Sep; 6(261):1667-71. PubMed ID: 20939401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of hepatic encephalopathy and future treatment options.
    González-Regueiro JA; Higuera-de la Tijera MF; Moreno-Alcántar R; Torre A
    Rev Gastroenterol Mex (Engl Ed); 2019; 84(2):195-203. PubMed ID: 31014748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Importance of hyperammoniemia of the renal origin in the pathogenesis of hepatic coma released in cirrhotic patients by diuretics generating hypokaliemia].
    Imler M; Bockel R; Peter B; Kieny R; Stahl J
    Pathol Biol (Paris); 1969 Jan; 17(1):5-19. PubMed ID: 4895969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.